Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission

Kusuma Chaiyasoot1,2,3, Naomi S Sakai4, Roxanna Zakeri1

  • 1Department of Medicine, Centre for Obesity Research, University College London, London, UK.

Obesity Surgery
|November 1, 2023
PubMed
Abstract

Insights

Type 2 diabetes remission after bariatric surgery is linked to improved beta-cell function and acyl ghrelin levels. Targeting visceral adipose tissue and branched-chain amino acid metabolism may enhance remission rates.

Area of Science:

  • Metabolic surgery research
  • Diabetes remission mechanisms
  • Obesity and metabolic health

Background:

  • Bariatric surgery effectively treats type 2 diabetes (T2D) in many patients, but remission mechanisms are not fully understood.
  • Identifying factors beyond weight loss is crucial for optimizing T2D remission strategies.
  • This study investigates clinical, metabolic, and genetic predictors of T2D remission post-surgery.

Purpose of the Study:

  • To identify weight-loss independent factors associated with type 2 diabetes remission after bariatric surgery.
  • To explore novel clinical, metabolic, and genetic associations with T2D remission.
  • To comprehensively phenotype patients who achieved T2D remission versus those who did not.

Main Methods:

  • Matched observational study comparing 10 T2D remitters and 10 non-remitters.
  • Detailed phenotyping including body composition (MRI), gut hormones, metabolomics, and insulin sensitivity.
  • Assessment of genetic risk scores for T2D and anthropometric traits.

Main Results:

  • Remitters exhibited enhanced beta-cell function and higher circulating acyl ghrelin levels.
  • Lower visceral adipose tissue (VAT) to subcutaneous adipose tissue (SAT) ratio was observed in remitters.
  • Branched-chain amino acids (BCAAs) and VLDL particle size were key discriminant metabolites; BCAAs correlated positively with VAT and negatively with beta-cell function.

Conclusions:

  • A novel relationship between VAT and BCAAs may influence glucoregulatory control.
  • Improved beta-cell function and ghrelin's role are key to T2D remission post-surgery.
  • Targeting VAT reduction and BCAA metabolism could improve long-term T2D remission rates.

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
556
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
331